President of Woody Hollow, Dr. Klaunig's research has focused on understanding the toxicological and pathological effects of chemical agents including pharmaceuticals. His work has concentrated primarily in the area of chemically induced carcinogenesis with particular interest in the mechanisms by which agents induce liver and lung cancer. A foundation of his mechanistic studies has been the application of these results to further understanding and producing scientifically based human risk assessment. His laboratory has been continually funding since 1984. Since joining Indiana University in 1991, he has been responsible for the acquisition of approximately $20 million in extramural funding. His funding sources have been from the Department of Defense, NIH, US EPA, the State of Indiana and corporate sources. The Klaunig Lab Laboratory (klauniglab.com) has produced 240 peer-reviewed publications, as well as, numerous meeting abstracts and over 15 book chapters. His chapter on carcinogenesis in the standard graduate textbook for toxicology (Casarett and Doull), is read by the majority of graduate and post-doctoral students in the field of toxicology. His publications are highly referenced and cited as is evident by his recent designation as a highly cited author in pharmacology and toxicology by the Thomson Reuters. This honor ranks him in the top 133 authors that published in the field of pharmacology and toxicology during the 2002-2012 timespan. His research involves the application of systems biology, pathology and toxicology and is highly hypothesis driven.
Woody Hollow LLC has not received any reviews.
Woody Hollow LLC has not received any endorsements.